Concepedia

Christina M. Fitzsimmons

CM

6

Publications

249

Citations

6

H-Index

2018

Active since

Affiliations

National Institutes of Health(Current)

Center for Cancer Research

National Cancer Institute

Chan Zuckerberg Initiative (United States)

University of California, Berkeley

Christina M. Fitzsimmons is an author at National Institutes of Health specializing in crispr, medicine, and gene expression.

ORCID

Top concepts

Publications per year

2018–2024

6

Publications

6

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

Kale Kundert, James E. Lucas, Kyle E. Watters et al. · Nature Communications · 2019 · 185 citations · Full text

Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs

Kale Kundert, James E. Lucas, Kyle E. Watters et al. · 2018 · 18 citations · Full text

, , +13

The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors

Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet et al. · Molecular Cancer Therapeutics · 2023 · 14 citations · Full text

Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma

Ruchi P. Patel, Joanna R. Thomas, Katherine M. Curt et al. · Investigative Ophthalmology & Visual Science · 2021 · 11 citations · Full text

Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma

Christina M. Fitzsimmons, Mariana D. Mandler, Judith C. Lunger et al. · NAR Cancer · 2024 · 11 citations · Full text

Rows per page

1–5 of 6